Insider trading · Q3 2026 · CIK 1295947

Prestige Consumer Healthcare Inc. (PBH) insider trading.

Name: Prestige Consumer Healthcare Inc. insider transactions, Q3 2026
Creator: U.S. Securities and Exchange Commission

In Q3 2026, insiders at Prestige Consumer Healthcare Inc. reported 5 non-derivative transactions on 5 Forms 3, 4 and 5: 0 open-market purchases and 0 sales.

Transactions: 5
Purchases (P): 0
Sales (S): 0
Net shares, P minus S: 0
Insiders: 5
Last filed: 2026-08-05

Insiders

Insider	Relationship	Transactions
Byom John E	Director	1
Clark Celeste A.	Director	1
DArecca James	Director	1
Kelly John F.	Director	1
Zier Dawn M.	Director	1

Transactions

5 non-derivative rows, newest transaction first. Shares and prices as filed.
Date	Insider	Code	Shares	Price	Owned after	Filing
2026-08-04	Byom John E	A (A)	2,981	$0	54,575	Form 4
2026-08-04	Clark Celeste A.	A (A)	2,981	$0	16,511	Form 4
2026-08-04	DArecca James	A (A)	2,981	$0	9,572	Form 4
2026-08-04	Kelly John F.	A (A)	2,981	$0	7,832	Form 4
2026-08-04	Zier Dawn M.	A (A)	2,981	$0	19,514	Form 4

Transaction codes in this quarter

A: 5

Get PBH insider transactions through the API

Request with your API key

curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1295947&limit=100" \
  -H "Authorization: Bearer $SEC_API_KEY"

Insider trading API guide · PBH company page · Prestige Consumer Healthcare Inc. on SEC.gov

Questions

Are insiders buying or selling Prestige Consumer Healthcare Inc. (PBH)?

In Q3 2026, insiders at Prestige Consumer Healthcare Inc. reported 5 non-derivative transactions on 5 Forms 3, 4 and 5: 0 open-market purchases and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.

Where do these Prestige Consumer Healthcare Inc. insider trades come from?

From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.

Source: SEC Insider Transactions Data Sets, Q3 2026, retrieved 2026-10-27. Footnotes, derivative holdings and amendments are in the linked filings. Not investment advice.

Plain-text version for agents and LLMs: /insider-trading/pbh.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.